Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | 0.00% | +1.00% | -26.81% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 82.33 | 56.6 | 59.67 | 44.46 | - | - |
Enterprise Value (EV) 1 | 82.33 | 56.6 | 59.67 | 44.46 | 44.46 | 44.46 |
P/E ratio | - | - | - | -1.57 x | -2 x | -2.04 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 6.44 x | 1.24 x |
EV / Revenue | - | - | - | - | 6.44 x | 1.24 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -5.96 x | - | - | -1.49 x | -1.43 x | -1.33 x |
FCF Yield | -16.8% | - | - | -67.3% | -69.7% | -75.1% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 18,755 | 24,502 | 43,241 | 44,020 | - | - |
Reference price 2 | 4.390 | 2.310 | 1.380 | 1.010 | 1.010 | 1.010 |
Announcement Date | 17/03/22 | 30/03/23 | 14/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | 6.9 | 35.75 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -14.65 | -28.52 | -30.34 | -31.58 | -36.65 | -24.92 |
Operating Margin | - | - | - | - | - | -531.1% | -69.7% |
Earnings before Tax (EBT) 1 | - | - | - | - | -30.85 | -35.38 | -37.75 |
Net income 1 | -8.557 | - | - | - | -30.85 | -35.38 | -37.75 |
Net margin | - | - | - | - | - | -512.8% | -105.58% |
EPS 2 | -3.020 | - | - | - | -0.6450 | -0.5050 | -0.4950 |
Free Cash Flow 1 | - | -13.82 | - | - | -29.9 | -31 | -33.4 |
FCF margin | - | - | - | - | - | -449.28% | -93.43% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 31/03/21 | 17/03/22 | 30/03/23 | 14/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -5.849 | -6.145 | -7.179 | -7.399 | -7.798 | -7.525 | -7.715 | -7.169 | -7.928 | -8.562 | -7.629 | -7.925 | -8.236 | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | - | - | - | - | - | - | - | -8.562 | -7.55 | -7.81 | -8.188 | - | - |
Net income 1 | - | - | - | - | - | - | - | - | - | -8.562 | -7.55 | -7.81 | -8.188 | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | - | - | - | - | - | - | - | - | - | -0.2000 | -0.1750 | -0.1650 | -0.1350 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 17/03/22 | 12/05/22 | 12/08/22 | 10/11/22 | 30/03/23 | 12/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | 09/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -13.8 | - | - | -29.9 | -31 | -33.4 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share 2 | - | - | - | - | -0.9200 | -0.7200 | -0.5700 |
Capex 1 | - | - | - | - | 0.16 | 0.33 | 0.4 |
Capex / Sales | - | - | - | - | - | 4.71% | 1.12% |
Announcement Date | 31/03/21 | 17/03/22 | 30/03/23 | 14/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.81% | 44.46M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- INAB Stock
- Financials IN8bio, Inc.